Search results
Found 9621 matches for
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
Environmental Sustainability at the Kennedy
We take sustainability seriously. Our research labs are 100% LEAF accredited. Our Sustainability Club meets monthly to drive down the carbon footprint of our science.
Case study: Building the Next Generation Biomedical Imaging Technologies
The Oxford-ZEISS Centre of Excellence in Biomedical Imaging (Oxford-ZEISS CoE) is more than a bioimaging facility – it’s a space where together with ZEISS Research and Development (R&D) Oxford’s researchers conceive and create new methodologies exploiting the latest commercial ZEISS microscopy technology. The Oxford-ZEISS CoE is a strategic partnership between the Carl ZEISS AG, the Institute for Developmental and Regenerative Medicine (IDRM), and the Kennedy Institute of Rheumatology (KIR) at the University of Oxford. This partnership represents an ideal collaboration between academia and industry for solving biological problems. This case study will describe the partnership at the heart of the centre, its role as a melting pot for new imaging ideas, and how the centre’s ground-breaking technologies allow us to observe scientific processes in increasingly remarkable ways. The Oxford-ZEISS CoE will hold an official inaugural event on 21st February 2024 which will showcase the success of the Oxford-ZEISS partnership.